Malignant transformation initiated by MII-AF9: Gene dosage and critical target cells

被引：166

作者：

Chen, Weili ^{[4
]}

Kumar, Ashish R. ^{[1
,4
]}

Hudson, Wendy A. ^{[4
]}

Li, Quanzhi ^{[4
]}

Wu, Baolin ^{[3
]}

Staggs, Rodney A. ^{[4
]}

Lund, Erik A. ^{[4
]}

Sam, Thien N. ^{[4
]}

Kersey, John H. ^{[1
,2
,4
]}

机构：

[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA

[3] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA

[4] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA

来源：

CANCER CELL | 2008年 / 13卷 / 05期

关键词：

CELLCYCLE;

D O I：

10.1016/j.ccr.2008.03.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The pathways by which oncogenes, such as MLL-AF9, initiate transformation and leukemia in humans and mice are incompletely defined. In a study of target cells and oncogene dosage, we found that MII-AF9, when under endogenous regulatory control, efficiently transformed LSK (Lin(-)Scal(+)c-kit(+)) stem cells, while committed granulocyte-monocyte progenitors (GMPs) were transformation resistant and did not cause leukemia. MII-AF9 was expressed at higher levels in hematopoietic stem (HSC) than GMP cells. MII-AF9 gene dosage effects were directly shown in experiments where GMPs were efficiently transformed by the high dosage of MII-AF9 resulting from retroviral transduction. MII-AF9 upregulated expression of 192 genes in both LSK and progenitor cells, but to higher levels in LSKs than in committed myeloid progenitors.

引用

页码：432 / 440

页数：9

共 31 条

[1] A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K
Traver, D
Miyamoto, T
Weissman, IL
[J]. NATURE, 2000, 404 (6774) : 193 - 197
[2] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
BENJAMINI, Y
HOCHBERG, Y
[J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
[3] Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein
Caslini, C
Serna, A
Rossi, V
Introna, M
Biondi, A
[J]. LEUKEMIA, 2004, 18 (06) : 1064 - 1071
[4] Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia
Chapiro, Elise
Russell, Lisa
Radford-Weiss, Isabelle
Bastard, Christian
Lessard, Michel
Struski, Stephanie
Cave, Helene
Fert-Ferrer, Sandra
Barin, Carole
Maarek, Odile
Della-Valle, Veronique
Strefford, Jonathan C.
Berger, Roland
Harrison, Christine J.
Bernard, Olivier A.
Nguyen-Khac, Florence
[J]. BLOOD, 2006, 108 (10) : 3560 - 3563
[5] A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy
Chen, Weili
Li, Quanzhi
Hudson, Wendy A.
Kumar, Ashish
Kirchhof, Nicole
Kersey, John H.
[J]. BLOOD, 2006, 108 (02) : 669 - 677
[6] An MII-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes
Corral, J
Lavenir, I
Impey, H
Warren, AJ
Forster, A
Larson, TA
Bell, S
McKenzie, ANJ
King, G
Rabbitts, TH
[J]. CELL, 1996, 85 (06) : 853 - 861
[7] Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors
Cozzio, A
Passegué, E
Ayton, PM
Karsunky, H
Cleary, ML
Weissman, IL
[J]. GENES & DEVELOPMENT, 2003, 17 (24) : 3029 - 3035
[8] The MII-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis
Dobson, CL
Warren, AJ
Pannell, R
Forster, A
Lavenir, I
Corral, J
Smith, AJH
Rabbitts, TH
[J]. EMBO JOURNAL, 1999, 18 (13) : 3564 - 3574
[9] Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells
Du, Y
Jenkins, NA
Copeland, NG
[J]. BLOOD, 2005, 106 (12) : 3932 - 3939
[10] Global and Hox-specific roles for the MLL1 methyltransferase
Guenther, MG
Jenner, RG
Chevalier, B
Nakamura, T
Croce, CM
Canaani, E
Young, RA
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (24) : 8603 - 8608

← 1 2 3 4 →